Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis

BACKGROUND: Intravenous administration of recombinant tissue plasminogen activator (rt-PA) fails to succeed in a subset of acute ischemic stroke (AIS) patients, while in approximately 6–8% of cases intracerebral hemorrhage (ICH) occurs as side effect. OBJECTIVE: Here, we aimed to investigate α2-plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Székely, Edina Gabriella, Orbán-Kálmándi, Rita, Szegedi, István, Katona, Éva, Baráth, Barbara, Czuriga-Kovács, Katalin Réka, Lóczi, Linda, Vasas, Nikolett, Fekete, István, Fekete, Klára, Berényi, Ervin, Oláh, László, Csiba, László, Bagoly, Zsuzsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334909/
https://www.ncbi.nlm.nih.gov/pubmed/35911531
http://dx.doi.org/10.3389/fcvm.2022.901286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334909/
https://www.ncbi.nlm.nih.gov/pubmed/35911531
http://dx.doi.org/10.3389/fcvm.2022.901286

Ejemplares similares